Cerner Co. (NASDAQ:CERN) Director William D. Zollars sold 4,100 shares of the company’s stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $62.16, for a total transaction of $254,856.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.
Shares of Cerner Co. (NASDAQ CERN) traded up $1.18 during trading hours on Monday, hitting $62.49. 2,686,857 shares of the stock were exchanged, compared to its average volume of 2,555,161. The company has a market cap of $20,910.00, a price-to-earnings ratio of 24.32, a price-to-earnings-growth ratio of 1.84 and a beta of 0.90. Cerner Co. has a 1 year low of $51.26 and a 1 year high of $73.86. The company has a quick ratio of 2.99, a current ratio of 3.01 and a debt-to-equity ratio of 0.11.
Cerner (NASDAQ:CERN) last issued its quarterly earnings results on Tuesday, February 6th. The company reported $0.58 EPS for the quarter, missing the Zacks’ consensus estimate of $0.61 by ($0.03). The company had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.33 billion. Cerner had a return on equity of 16.82% and a net margin of 16.86%. Cerner’s quarterly revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.61 EPS. research analysts forecast that Cerner Co. will post 2.42 earnings per share for the current fiscal year.
A number of brokerages recently commented on CERN. SunTrust Banks cut shares of Cerner from a “buy” rating to a “hold” rating in a research note on Tuesday, January 16th. They noted that the move was a valuation call. Zacks Investment Research lowered shares of Cerner from a “buy” rating to a “hold” rating in a report on Tuesday, January 16th. Royal Bank of Canada reaffirmed a “buy” rating on shares of Cerner in a report on Wednesday, October 25th. JPMorgan Chase & Co. lowered shares of Cerner from an “overweight” rating to a “neutral” rating in a report on Friday, October 27th. Finally, Leerink Swann reaffirmed a “hold” rating on shares of Cerner in a report on Saturday, November 25th. One investment analyst has rated the stock with a sell rating, twelve have given a hold rating and eight have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $67.05.
ILLEGAL ACTIVITY NOTICE: This story was first reported by American Banking News and is the sole property of of American Banking News. If you are reading this story on another site, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The original version of this story can be viewed at https://www.americanbankingnews.com/2018/02/12/cerner-co-cern-director-william-d-zollars-sells-4100-shares.html.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.